MBX-102/JNJ39659100, a Novel Non-TZD Selective Partial PPAR-𝛾 Agonist Lowers Triglyceride Independently of PPAR-𝛼 Activation
MBX-102/JNJ-39659100 (MBX-102) is a selective, partial PPAR-𝛾 agonist that lowers glucose in the absence of some of the side effects, such as weight gain and edema, that are observed with the TZDs. Interestingly MBX-102 also displays pronounced triglyceride lowering in preclinical rodent models and...
Saved in:
| Main Authors: | Apurva Chandalia, Holly J. Clarke, L. Edward Clemens, Bindu Pandey, Vic Vicena, Paul Lee, Brian E. Lavan, Francine M. Gregoire |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2009-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2009/706852 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PPARS and Obesity
by: Francine M. Gregoire, et al.
Published: (2007-01-01) -
Development of Synthetic Modulators of PPARs: Current Challenges and Future Opportunities
by: Francine M. Gregoire, et al.
Published: (2008-01-01) -
Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?
by: Roberto Scatena, et al.
Published: (2008-01-01) -
Metabolomics of the interaction between PPAR‐α and age in the PPAR‐α‐null mouse
by: Helen J Atherton, et al.
Published: (2009-04-01) -
PPARγ Agonists: Blood Pressure and Edema
by: Bonnie L. Blazer-Yost
Published: (2010-01-01)